ICON’s experience supporting early phase studies in subjects with renal and hepatic impairment, as well as our close contact with local IRBs, allows our team to expedite study start-up project activities and meet enrollment objectives. In addition to our Clinical Pharmacology Units, ICON has collaborated with additional sites with whom we have successfully executed previous renal and hepatic impairment studies.
ICON’s CPUs enroll these special populations using our robust database, which contains volunteers with renal and hepatic impairment. In addition, we regularly access special populations through our relationships with local physicians. Recognizing that the foundation for a successful study begins with successful recruitment, all our units have a dedicated team whose sole focus is recruiting and screening, regularly employing ongoing and study-specific media campaigns to enhance our ever-growing network of volunteers.
In the past five years, ICON has provided services for over 25 studies involving renal and/or hepatic impairment. This includes: